Ketamine

Ketamine psychedelic therapy (KPT): a review of the results of ten years of research

This review (1997) suggests that ketamine psychedelic therapy (KPT) could effectively treat alcoholism (AUD). Total abstinence at one year compared favourably (65.8% to 24%) to a group receiving conventional treatment.

Authors

  • Grinenko, A. Y.
  • Krupitsky, E. M.

Published

Journal of Psychoactive Drugs
meta Study

Abstract

Ketamine is a prescription drug used for general anesthesia. In subanesthetic doses, it induces profound psychedelic experiences and hallucinations. The subanesthetic effect of ketamine was the hypothesized therapeutic mechanism in the authors' use of ketamine-assisted psychotherapy for alcoholism. The results of a controlled clinical trial demonstrated a considerable increase in efficacy of the authors' standard alcoholism treatment when supplemented by ketamine psychedelic therapy (KPT). Total abstinence for more than one year was observed in 73 out of 111 (65.8%) alcoholic patients in the KPT group, compared to 24% (24 out of 100 patients) of the conventional treatment control group (p<0.01). The authors' studies of the underlying psychological mechanisms of KPT have indicated that ketamine-assisted psychedelic therapy of alcoholic patients induces a harmonization of the Minnesota Multiphasic Personality Inventory (MMPI) personality profile, positive transformation of non verbalized (mostly unconscious) self-concept and emotional attitudes to various aspects of self and other people, positive changes in life values and purposes. important insights into the meaning of life and an increase in the level of spiritual development. Most importantly, these psychological changes were shown to favor a sober lifestyle. The data from biochemical investigations showed that the pharmacological action of KPT affects both monoaminergic and opioidergic neurotransmitter metabolism, i.e., those neurochemical systems which are involved in the pathogenesis of alcohol dependence. The data from EEG computer-assisted analysis demonstrated that ketamine increases theta activity in cerebrocortical regions of alcoholic patients. This is evidence of the reinforcement of limbic cortex interaction during the KPT session.

Unlocked with Blossom Pro

Research Summary of 'Ketamine psychedelic therapy (KPT): a review of the results of ten years of research'

Study Details

Cited By (33)

Papers in Blossom that reference this study

Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation

Deijen, J. B., Engelbregt, H., Irrmischer, M. et al. · Psychopharmacology (2025)

2 cited
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems

Bryan, J. W., Clarke, T. I., Cleary, M. A. et al. · Psychopharmacology (2024)

Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm

Earleywine, M., MacConnel, H. A., Radowitz, S. · OSF Preprints (2024)

Therapeutic mechanisms of psychedelics and entactogens

Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)

Psychedelic therapy in the treatment of addiction: the past, present and future

Agnorelli, C., Barba, T., Erritzoe, D. et al. · Frontiers in Psychiatry (2023)

On the need for metaphysics in psychedelic therapy and research

Sjöstedt-Hughes, P. · Frontiers in Psychology (2023)

Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy-A systematized review

Baker, P., Bright, S. J., Bruno, R. et al. · Journal of Psychopharmacology (2022)

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review

Cleare, A. J., Knight, G., Ko, K. et al. · Frontiers in Psychiatry (2022)

Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy

Betzler, F., Gründer, G., Johnson, M. W. et al. · Current Addiction Reports (2021)

Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials

Forsyth, B., Lumley, T., Muthukumaraswamy, S. · Expert Review of Clinical Pharmacology (2021)

Show all 33 papers
Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature

Nigam, K. B., Pandurangi, A. K. · SN Comprehensive Clinical Medicine (2021)

A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties

Anderson, C., Chacko, E., Chen, J. et al. · Journal of Psychopharmacology (2021)

51 cited
Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial

Azhari, N., Dakwar, E., Haug, N. A. et al. · Journal of Psychopharmacology (2020)

Psychedelics and Psychotherapy

Johnson, M. W., Nayak, S. · Pharmacopsychiatry (2020)

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies

Breeksema, J. J., Krediet, E., Niemeijer, A. R. et al. · CNS Drugs (2020)

Reviewing the potential of psychedelics for the treatment of PTSD

Bostoen, T., Breeksema, J. J., Krediet, E. et al. · International Journal of Neuropsychopharmacology (2020)

The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: a systematic review

Kosten, T. R., Mathai, D. S., Meyer, M. J. et al. · Journal of Affective Disorders (2020)

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial

Basaraba, C. N., Choi, J., Dakwar, E. et al. · American Journal of Psychiatry (2020)

A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial

Basaraba, C. N., Carpenter, K. M., Choi, C. J. J. et al. · American Journal of Psychiatry (2019)

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Garcia-Romeu, A., Richards, W. A. · International Review of Psychiatry (2018)

Ketamine for the treatment of addiction: Evidence and potential mechanisms

Ezquerra-Romano, I. I., Krupitsky, E. M., Lawn, W. et al. · Neuropharmacology (2018)

Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review

Back, S. E., Brady, K. T., Jones, J. L. et al. · Frontiers in Psychiatry (2018)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Schenberg, E. E. · Frontiers in Pharmacology (2018)

The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions

Bogenschutz, M. P., Forcehimes, A. A., May, D. G. et al. · Frontiers in Pharmacology (2018)

Clinical Applications of Hallucinogens: A Review

Addy, P. H., Garcia-Romeu, A., Kersgaard, B. · Experimental and Clinical Psychopharmacology (2017)

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Lawn, W., McAndrew, A., Morgan, C. J. A. et al. · Current Opinion in Behavioral Sciences (2017)

Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism

Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)

Ketamine abuse potential and use disorder

Lin, D., Liu, Y., Wu, B. et al. · Brain Research Bulletin (2016)

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

Dakwar, E., Foltin, R. W., Hart, C. L. et al. · Molecular Psychiatry (2016)

Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences

Gallinat, J., Majic, T., Schmidt, T. T. · Journal of Clinical Psychopharmacology (2015)

Can psychedelic compounds play a part in drug dependence therapy?

Johnson, M. W., Sessa, B. · British Journal of Psychiatry (2015)

Therapeutic infusions of ketamine: do the psychoactive effects matter?

Anerella, C., Dakwar, E., Hart, C. L. et al. · Drug and Alcohol Dependence (2014)

Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up

Burakov, A. M., Dunaevsky, I. V., Grinenko, A. Y. et al. · Journal of Substance Abuse Treatment (2002)

Your Library